Diclofenac Potassium

双氯芬酸钾

Report date: 2026/04/13 20:02:18
NME

Base Information

Drug NameDiclofenac Potassium
Drug Alias Name扶他捷凯扶兰KaflanCataflamDeflox
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsPainFeverPain, Postoperative +[12] 
Global Approved IndicationsPainDysmenorrheaInflammation +[5] 
Approved Indications in ChinaPainInflammation
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesSaudi ArabiaEgypt +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesAssertio Specialty Pharmaceuticals LlcAl-Azhar UniversityShandong Keyuan Pharmaceutical Co Ltd
Inactive CompaniesHumanis Saglık Anonim SirketiImam Abdulrahman Bin Faisal UniversityXanodyne Pharmaceuticals Inc +[4] 
Active IndicationsPainInflammationMigraine Disorders +[6] 
Inactive IndicationsFeverPain, PostoperativeDysmenorrhea +[6] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG